Category Archives: Uncategorized

Investigators evaluated a water-free cyclosporine formulation (CyclASol) for moderate to severe dry eye disease. Source: AAO

• Posted on: Jul 1 2019
• By: Saratoga Opthalmology
• Leave a response

Investigators report outcomes of wavefront-guided photorefractive keratectomy (WG-PRK) for high astigmatism after keratoplasty. Source: AAO

• Posted on: Jun 28 2019
• By: Saratoga Opthalmology
• Leave a response

This week, Orion’s visual prosthesis gives the Argus II a run for its money, a Brazilian startup presents an affordable and portable ophthalmoscope and an international team eradicates Botswana’s backlog of 6,000 cataract blindness cases. Source: AAO

• Posted on: Jun 28 2019
• By: Saratoga Opthalmology
• Leave a response

This study compared the incidence of intraoperative floppy-iris syndrome (IFIS) in male and female patients undergoing cataract surgery. Source: AAO

• Posted on: Jun 27 2019
• By: Saratoga Opthalmology
• Leave a response

AbbVie has agreed to acquire Allergan for $63 billion, unlocking key opportunities for growth on both sides of the deal. Source: AAO

• Posted on: Jun 26 2019
• By: Saratoga Opthalmology
• Leave a response

Investigators explored the incidence of and risk factors for developing persistent low-pressure syndrome after lumbar puncture (LP) in patients with idiopathic intracranial hypertension (IIH). Source: AAO

• Posted on: Jun 26 2019
• By: Saratoga Opthalmology
• Leave a response

This prospective study investigated the efficacy and safety of pembrolizumab as a first-line therapy for metastatic uveal melanoma. Source: AAO

• Posted on: Jun 25 2019
• By: Saratoga Opthalmology
• Leave a response

Investigators of this multicenter study evaluated long-term outcomes of a progressively enlarging prosthesis with dermis fat grafting for congenital anophthalmia. Source: AAO

• Posted on: Jun 24 2019
• By: Saratoga Opthalmology
• Leave a response

This week, a geneticist unveils the world’s first keratoconus mouse, an ophthalmology researcher with vision loss advocates for an inclusive workforce and new findings challenge the benefits of complement inhibitors in retinal degeneration. Source: AAO

• Posted on: Jun 21 2019
• By: Saratoga Opthalmology
• Leave a response

Researchers examined the effectiveness of topical carbomer-based lipid-containing artificial tears (CLAT) and hyaluronate (HU) in patients with dry eye disease. Source: AAO

• Posted on: Jun 21 2019
• By: Saratoga Opthalmology
• Leave a response